Senior MSL - Central Territory

We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.

We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.

Valneva USA is focused on the marketing and distribution of vaccines for Japanese encephalitis and chikungunya.

The Senior Medical Science Liaison (MSL), Central Territory, is a senior field medical role responsible for scientific engagement with external stakeholders across Central United States. The role serves as a credible, accessible scientific partner to healthcare professionals, key external experts, researchers, public-health leaders, and healthcare-system decision-makers.